Bordetella bronchiseptica is a Gram-negative bacterium that infects and causes disease in a wide variety of animals. B. bronchiseptica also infects humans, thereby demonstrating zoonotic transmission. An extensive characterization of human B. bronchiseptica isolates is needed to better understand the distinct genetic and phenotypic traits associated with these zoonotic transmission events. Using whole-genome transcriptome and CGH analysis, we report that a B. bronchiseptica cystic fibrosis isolate, T44625, contains a distinct genomic content of virulence-associated genes and differentially expresses these genes compared to the sequenced model laboratory strain RB50, a rabbit isolate. The differential gene expression pattern correlated with unique phenotypes exhibited by T44625, which included lower motility, increased aggregation, hyperbiofilm formation, and an increased in vitro capacity to adhere to respiratory epithelial cells. Using a mouse intranasal infection model, we found that although defective in establishing high bacterial burdens early during the infection process, T44625 persisted efficiently in the mouse nose. By documenting the unique genomic and phenotypic attributes of T44625, this report provides a blueprint for understanding the successful zoonotic potential of B. bronchiseptica and other zoonotic bacteria.
B
ordetellae are Gram-negative respiratory bacterial pathogens. Bordetella pertussis and Bordetella parapertussis hu are highly infectious and cause the acute disease whooping cough in humans (1) . In contrast, B. bronchiseptica infects a broad range of mammals, causing diseases ranging from lethal pneumonia to asymptomatic chronic infection. B. bronchiseptica typically persists in the upper respiratory tract of rats and mice for extended periods of time (2) (3) (4) (5) (6) . Comparative genome sequencing analysis of strains from these three Bordetella species has revealed a loss or inactivation of a large number of genes in B. pertussis and B. parapertussis hu compared to B. bronchiseptica, indicating that host restriction is due primarily to the loss of genes or gene function as opposed to the acquisition of foreign DNA (7) . These results have led to the proposal that B. bronchiseptica is the closest evolutionary ancestor of these strains (3, 7, 8) .
The bordetellae express many virulence factors, such as adhesins, multiple secretion systems, autotransporters, polysaccharides, and toxins (5, (9) (10) (11) . While B. bronchiseptica contains nearly all the genes encoding virulence factors found in B. pertussis and B. parapertussis hu , each subspecies expresses a different repertoire (7, 12) . These differences in gene expression are thought to contribute to the variation in host range and severities of disease (7, 12) . Since B. bronchiseptica is more genetically and clinically diverse than the other classical bordetellae, it was hypothesized that strains from different phylogenetic lineages of B. bronchiseptica utilize different sets of virulence factors (5, 8, (12) (13) (14) . Several studies have recently confirmed this hypothesis (15) (16) (17) .
An estimated 75% of emerging diseases in humans arise from zoonotic sources (18) . Domesticated animal populations are often overlooked as sources of zoonotic agents, resulting in a dearth of knowledge on the genetic and phenotypic attributes of these pathogens that contribute toward successful zoonotic infections and diseases. Each zoonotic event provides the opportunity for the adaptation of pathogens to human hosts and, as a result, the emergence of new human infectious diseases (19) .
B. bronchiseptica is frequently associated with respiratory disease in a variety of companion and farm animals to which humans are frequently exposed. While more frequent in immunocompromised individuals, human infections in healthy adults and children do occur, thereby demonstrating zoonotic transmission (5, 14, (20) (21) (22) (23) (24) . Since B. bronchiseptica is usually not suspected in humans, it is likely that the incidence of B. bronchiseptica-induced illness is underestimated. Several recent reports have demonstrated the isolation of B. bronchiseptica from cystic fibrosis (CF) patients (25) (26) (27) (28) (29) (30) (31) . Zoonotic transmission from family pets exhibiting an acute respiratory illness was hypothesized in many of these cases. We recently reported the isolation and molecular typing of B. bronchiseptica isolate T44625, cultured from a sputum sample of a pediatric CF patient recently exposed to a kitten with a history of respiratory illness (29) . Based on multilocus sequence type (MLST) analysis, T44625 is an ST27 strain, which is found in clonal complex 1 of an MLST-based Bordetella phylogeny (8, 29) . Unlike most other STs in complex 1, which consist of B. bronchiseptica strains primarily isolated from animals, ST27 strains are primarily isolated from human infections (8) . Excluding those of unknown origin, ϳ71% (10/14) of the remaining ST27 isolates were cultured from humans, with the remainder isolated from dogs.
A full molecular characterization of these human isolates of B.
bronchiseptica strains is needed for both public health preparedness and a better understanding of the genetic and phenotypic traits associated with these zoonotic transmission events. Conducting these investigations will also allow us to better understand the mechanisms and environmental and pathogen-specific factors that lead to exposure and cross-species transmission of this pathogen. This is particularly important in determining the zoonotic potential of Bordetella infections.
In this report, we used a combination of multiple whole-genome and phenotypic approaches to characterize and compare T44625 to the most widely studied and sequenced laboratory reference strain, RB50.
MATERIALS AND METHODS
Bacterial strains and growth conditions. B. bronchiseptica strain T44625 is a clinical isolate recently obtained from a sputum sample of a cystic fibrosis patient exposed to a kitten with an acute respiratory illness (29) . B. bronchiseptica strain RB50 is a rabbit isolate that has been extensively characterized and serves as a laboratory reference strain, and the complete genome sequence has been obtained (7, 32, 33) . RB54 is a Bvg Ϫ phaselocked derivative of RB50 (32) , and RB53 is a Bvg ϩ phase-locked derivative. Bordetella strains were grown at 37°C on Bordet-Gengou (BG) agar (Difco, Sparks, MD) supplemented with 7.5% defibrinated sheep blood or in Stainer-Scholte (SS) broth (34) .
RNA isolation. Two independent biological replicates of RB50 and T44625 were grown in SS broth, subcultured at a starting optical density at 600 nm (OD 600 ) of 0.02 into 50 ml of SS broth, grown at 37°C for 24 h with shaking, and harvested in logarithmic phase (OD 600 , 1.0) by centrifugation at 3,700 rpm for 10 min. Total RNA was extracted with using the Qiagen RNeasy kit (Qiagen, Valencia, CA) according to the manufacturer's instructions.
Microarray hybridization and expression analysis. A 2-color hybridization format was used for the microarray analysis. For each biological replicate, prepared RNA was first treated with DNase I (Promega, Madison, WI) to remove genomic DNA, and then RNA extracted from T44625 was used to generate Cy5-labeled cDNA. RNA extracted from RB50 was used to generate Cy3-labeled cDNA. Additionally, dye-swap experiments, in which the fluorescent labels were exchanged to ensure that uneven incorporation did not confound our results, were performed analogously. Fluorescently labeled cDNA copies of the total RNA pool were prepared, and the two differentially labeled reactions to be compared were then mixed, followed by buffer exchange, purification, and concentration as described previously (15, 16, 33, 35, 36) . The two differentially labeled reactions to be compared were combined and hybridized to an RB50-specific long-oligonucleotide microarray (35) . Slides were then scanned using a GenePix 4000B microarray scanner and analyzed with GenePix Pro software (Axon Instruments, Union City, CA). Spots were assessed visually to identify those of low quality, and arrays were normalized so that the median of ratios across each array was equal to 1.0. Spots of low quality were identified and were filtered out prior to analysis. Ratio data from the biological replicates were compiled and normalized based on the total Cy3 percent intensity and Cy5 percent intensity to eliminate slideto-slide variation. Gene expression data were then normalized to 16S rRNA. The statistical significance of the gene expression changes observed was assessed by using the significant analysis of microarrays (SAM) program (37) . A one-class unpaired SAM analysis using a false discovery rate of 0.05% was performed.
CGH analysis. For DNA isolation, RB50 and T44625 were grown in SS broth at 37°C with shaking overnight, and genomic DNA was isolated using a DNA extraction kit (Qiagen, Valencia, CA) according to the manufacturer's instructions and digested with DpnII. For each labeling reaction, 2 g of digested genomic DNA was randomly primed using Cy5 and Cy3 dye-labeled nucleotides with BioPrime DNA labeling kits (Invitrogen, Carlsbad, CA), and the two differentially labeled reactions to be compared were combined and hybridized to an RB50-specific long-oligonucleotide microarray (15, 16, 35) . Dye-swap experiments were performed. Statistical analysis of comparative genomic hybridization (CGH) data was performed with SAS software 9.1.3 (SAS Institute, Inc., Cary, NC). Regions of difference (RDs), meaning genes that are either divergent or absent, were identified using a MODECLUS procedure (PROC MODECLUS) based on nonparametric density estimation. All genes are labeled as annotated in the RB50 genome (7) . cDNA preparation and quantitative reverse transcription-PCR (qRT-PCR). Prepared RNA was first treated with DNase I (Promega, Madison, WI) to remove contaminant genomic DNA. DNase-treated total RNA (1 g) from each biological replicate was then reverse transcribed using 300 ng of random oligonucleotide hexamers and SuperScript III RTase (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol. Mock reactions were performed in parallel, without the addition of reverse transcriptase, to confirm the absence of genomic contaminants. Resulting cDNA was then stored at Ϫ20°C until needed. The resulting cDNA was diluted 1:25, and 1 l of this dilution and a blank control without cDNA were used as templates and were amplified using the TaqMan universal PCR master mix (Applied Biosystems, Foster City, CA). Primers were designed using Primer Express (Applied Biosystems, Foster City, CA) to obtain similarly sized amplicons for bcfA, flaA, fhaB, and fimA (38) and are listed in Table 1 . The probe was labeled using 6-carboxyfluorescein as the quencher and 6-carboxytetramethylrhodamine as the fluorophore. Calculations for comparison between samples were performed using the ⌬⌬C T method with the housekeeping gene recA being used as the standardization control, as described previously (38) .
PCR. Genomic DNA was isolated from RB50 and T44625 and screened for the presence of the classical or alternative wbm gene, cyaA, ptp, bipA, and the housekeeping gene adk using primers listed in Table 1 . (Table 1) . Overlapping amplicons covering up-and downstream regions of the 5= and 3= ends of fim2 were obtained using primer sets fim2_pcr-F/fim2_pcr-R1, fim2_pcr-F/ fim2_pcr-R2, and fim2_pcr-F/fim2_pcr-R3. PCR was performed using the following cycling conditions: 95°C for 5 min; 30 cycles of 95°C for 30 s, 55°C for 30 s, and 72°C for 1 min; and a final elongation of 72°C for 7 min. Reaction mixtures contained a final concentration of 1.5 mM MgCl 2 , 200 M each deoxynucleotide triphosphate, 2.5 U of Taq polymerase, and 0.5 M each primer in a final volume of 50 l. Following confirmation of a single PCR product by agarose gel electrophoresis, amplicons were purified using spin columns (Qiagen, Valencia, CA) and sequenced directly by fluorescence-based cycle sequencing with AmpliTaq and BigDye Terminators on an ABI 377 sequencer at the Iowa State University Genomics Facility. The Lasergene 10 software package (DNA Star, Madison, WI) was used for sequence editing and analysis. The final fim2 sequence for strain T44625 represents a minimum of 3-fold coverage with at least one read from each strand. The GenBank accession number for the T44625 fim2 sequence is KJ152684, and the GenBank accession number for the T44625 fim2 sequence along the upstream region containing the poly(C) track is KJ152685.
Genome analysis. Genomic sequences were obtained from GenBank for the following B. bronchiseptica strains: RB50 (NC_002927), 253 (NC_019382), 1289 (HE983626), MO149 (HE965807), Bbr77 (HE983628), and D445 (HE983627). Sequence comparisons were performed using Geneious Pro 5.0.2 (Biomatters Inc., Auckland, New Zealand) and the NCBI BLAST program (http://blast.ncbi.nlm.nih.gov/).
Motility assay. Strains were freshly grown on BG agar plates at 37°C. Individual colonies were picked and stab inoculated into 0.8% Luria broth (LB) agar motility plates using a sterile pipette tip and grown overnight at 37°C. Motile organisms display outward migration from the point of inoculation. Zones of migration were measured for each strain. Strains were spotted at least 7 times per plate, and the experiment was performed in triplicate. Results were analyzed for significance using the Student t test, and a P value of less than 0.05 was considered significant.
Cell aggregation assays. RB50 and T44625 were grown in SS overnight at 37°C. Bacterial cells were harvested, homogenized, and subcultured in SS. At each time interval, 6 samples were collected by centrifugation at 650 ϫ g for 2 min. Three of these samples were homogenized before centrifugation and three were not. The OD was then measured from the supernatant, and the aggregation index (AI) was calculated based on the following equation: (OD homogenized Ϫ OD nonhomogenized )/ OD homogenized . To calculate the percentage of cells in solution, RB50 and T44625 were grown overnight in 2 ml SS at 37°C. Cells were harvested and vortexed vigorously to disrupt the aggregates. Homogenized cells were kept at room temperature in tubes with minimal disturbance. One hundred l of cells was taken at indicated time intervals from the top layer, and the OD was measured. The percentage of cells in solution was calculated based on the OD at various times over the initial OD. Two independent experiments were performed in triplicate. Results were analyzed for significance using the Student t test, and a P value of less than 0.05 was considered significant.
Microtiter plate assay of biofilm formation. Biofilm formation was examined using a microtiter dish assay as previously described (11, 39) . Bordetella strains were inoculated at an OD 600 of 0.05 into 1.5 ml of SS broth in a 12-well polyvinylchloride microtiter plate. Plates were sealed with tape and incubated at 37°C. At the indicated time points, media and planktonic cells were removed and the plates were vigorously washed to remove loosely adherent cells. The remaining cells were stained with 0.1% crystal violet (CV), incubated at room temperature for 30 min, and then washed. CV staining of the cells was solubilized with 1.5 ml of 100% ethanol. The solubilized CV was quantitated by transferring 125 l to a new microtiter dish and determining the OD 540 . The experiment was performed in groups of six wells, and the results were analyzed for significance using the Student t test; a P value less than 0.05 was considered significant.
Bacterial adhesion assays. Rat lung epithelial (L2) and human alveolar epithelial (A549) cells were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS) and 4 mM L-glutamine at 37°C under 5% CO 2 . Cells were harvested at 90% confluence, seeded at approximately 2 ϫ 10 5 cells per well into 24-well tissue culture plates, and incubated overnight at 37°C under 5% CO 2 . Plates were then inoculated with bacterial suspensions prepared from RB50 or T44625 cultures collected in mid-log phase and then diluted to 2 ϫ 10 6 CFU/ml using growth media to a multiplicity of infection (MOI) of 10. Dilutions of bacterial inocula were plated on BG agar plates to determine CFU counts and verify the MOI. Adhesion assays were carried out in triplicate and performed by removing growth medium from cells and then adding either medium alone or 1 ml of bacterial inoculum. Plates were then centrifuged for 5 min at 900 rpm and incubated at 37°C with 5% CO 2 for 15 min in order to facilitate contact between bacteria and epithelial cells. The medium was then removed and the wells were washed four times with sterile phosphate-buffered saline (PBS) to remove any nonattached bacteria. The eukaryotic cells were then lysed with 0.05% saponin, and the number of adherent bacteria was enumerated by plating dilutions on BG agar plates. CFU counts were then used to calculate the proportion of adherent bacteria, expressed as a percentage of the original inoculum. Results were analyzed for significance using the Student t test, and a P value of less than 0.05 was considered significant.
Animal experiments. All housing, husbandry, and experiments were carried out in accordance with the guidelines approved by the Institutional Animal Care and Use Committee. Six-to 7-week-old female C57/ BL6 mice were obtained from Jackson Laboratories. For inoculation, strains were grown to logarithmic phase (OD 600 , 1.0) and diluted in PBS to the appropriate concentration. Inocula were confirmed by plating dilutions on BG agar plates and counting the resulting colonies after 2 days of incubation at 37°C. Mice were lightly anesthetized with isoflurane and intranasally inoculated with 5 ϫ 10 5 CFU of RB50 or T44625 in 25 l of sterile PBS. Mice were sacrificed at 1, 3, 15, 30, and 60 days postinoculation by isoflurane inhalation, and the entire nasal septum, 1 cm of trachea, and left lung lobes were harvested and homogenized in sterile PBS. The CFU content of each organ was determined by plating dilutions on BG agar plates and counting the resulting colonies after 2 days of incubation at 37°C. Statistical analyses were carried out by Student's t test, and a P value of less than 0.05 was considered significant.
To obtain convalescent-phase sera, blood was collected from infected mice 30 days postinoculation, and serum was separated from the blood by centrifugation at 500 ϫ g for 10 min.
SDS-PAGE and immunoblot analyses. Strains were grown to logarithmic phase (OD 600 , 1.0) in SS broth and harvested by centrifugation at 3,700 rpm for 10 min. Whole-cell extracts (WCE) were then prepared as previously described (38) . Protein concentrations were quantitated using the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA). Equal amounts of proteins were separated using 12% SDS-polyacrylamide gels, transferred to nitrocellulose membranes, and probed with convalescentphase sera (1:1,000 dilution) obtained from RB50-or T44625-infected mice 30 days postinoculation. A 1:2,000 dilution of horseradish peroxidase (HRP)-conjugated goat anti-mouse antibody (Southern Biotech, Birmingham, AL) was used as the secondary antibody, and bands were visualized using the ECL Western blotting detection reagents (Amersham Biosciences, Piscataway, NJ). 
RESULTS
Genes encoding O antigen, bipA and fim2, are highly divergent, and the ptp operon has replaced the cya operon in T44625. To begin the characterization of T44625, we performed comparative genomic hybridization (CGH) analysis in order to identify coding regions of T44625 that are either absent or contain a high degree of sequence divergence from RB50. Of the 5,013 genes analyzed, 137 genes were identified as statistically significant regions of difference (RDs), meaning that these are either divergent or absent from T44625 relative to RB50. Most of the RDs were clustered along the chromosome, indicating either large-scale loss or insertion of genes in T44625 ( Fig. 1 ; also see the supplemental material). Of the statistically significant RDs identified, 76 are phage-related genes and comprised the majority of divergent clusters. Five virulencerelated genes were identified as divergent in T44625 and include fimbrial serotype 2 (fim2), 3 O-antigen-related genes (wbmS, wbmR, and wbmO), and Bordetella intermediate-phase protein A (bipA). Other divergent genes in strain T44625 include 8 genes annotated in the RB50 genome (7) as hypothetical, putative, or probable proteins, 7 metabolism genes, 7 transport genes, 7 periplasmic/exported or lipoprotein genes, 5 transcriptional regulators, 2 plasmid-related genes, a putative ferric siderophore receptor (bfrH), and an autotransporter (bapA). These data suggest that T44625 contains a flexible set of genes compared to RB50.
Previously, several B. bronchiseptica strains were demonstrated to encode genes for either the classical (wbmO-R and BB0124-BB0127) or alternative (wbmO-U) loci (40) . Since the O-antigenrelated genes (wbmS, wbmR, and wbmO) were identified as RDs in T44625, we hypothesized that T44625 contains genes encoding the alternative (wbmO-U) O antigen (40) . To test this, RB50 and T44625 were PCR screened for the presence of classical or alternative O-antigen genes, along with the housekeeping adenylate kinase (adk) as a positive control. adk was amplified from both RB50 and T44625 (Fig. 2A) . The classical O-antigen gene BB0127 was only amplified from RB50, while the alternative O-antigen gene, BPP0127 (wbmR), was only amplified from T44625 ( Fig.  2A) . These data suggest that T44625 contains genes encoding the alternative O antigen or O2 serotype.
B. bronchiseptica strains of the phylogenetic lineage ST27 lack the cya operon, encoding genes responsible for the production and secretion of adenylate cyclase toxin (ACT), due to replacement by a novel oligopeptide binding and transport operon referred to as ptp (15) . We have previously shown that T44625 lacks cyaA and is nonhemolytic on BG agar plates (29) . Since T44625 is an ST27 strain, we tested if the cyaA operon has been replaced by the ptp operon in T44625 by PCR amplification of cyaA or ptp genes from T44625 and RB50. cyaA was amplified from RB50 but not from T44625 (Fig. 2B) . In contrast, ptp was amplified from T44625 and not from RB50 (Fig. 2B) . adk was amplified from both B. bronchiseptica strains (Fig. 2B) . These data suggest that, similar to other strains of the B. bronchiseptica lineage ST27, the cya operon has been replaced by the ptp operon in T44625.
bipA is a well-characterized BvgAS-regulated gene that was also identified as RD in strain T44625. BipA is an outer membrane protein expressed maximally during the Bvg-intermediate phase (41) (42) (43) . Given that T44625 is an ST27 strain, we reasoned that it shares significant sequence similarity with other ST27 strains. Using the RB50 genome sequence (7) as a reference for comparison, the sequenced genome of strain 253 (17) , another ST27 strain, was examined for the presence of bipA. No gene or open reading frame corresponding to the RB50 bipA sequence could be identified in strain 253 (data not shown). We next performed PCR amplification of bipA in T44625. bipA could be amplified from strain RB50 and not from strain T44625, and the housekeeping gene, adenyl- ate kinase (adk), was amplified from both B. bronchiseptica strains (Fig. 2C) . These data suggest that bipA is absent from strain T44625.
fim2 encodes one of the several fimbrial subunits expressed by B. bronchiseptica (7, 44) . The genome sequence of 253 contains an annotation for a fim2 gene (BN112_4742). DNA sequences of PCR amplicons containing the fim2 gene from strain T44625 revealed that fim2 from T44625 is 100% identical to fim2 from 253, including a poly(C) tract located 58 bp upstream of the start codon. A sequence alignment revealed that fim2 from 253 and T44625 is only 84% identical to fim2 from RB50, and sequence polymorphisms were identified throughout the coding sequence (Fig. 2D ). In comparison, fim2 genes from strains 1289, MO149, Bbr77, and D445 are 99%, 93%, 93%, and 73% identical to fim2 from RB50, respectively (Fig. 2D) . The fim2 genes from 253 (ST27) and strain D445 (an ST17 isolate), which are the most divergent from RB50, are also substantially different from each other, with only 77% identity (Fig. 2D) . Additionally, a greater number of sequence polymorphisms was identified within the probe region for each of the six strains compared to the entire coding region, decreasing the nucleotide identity within the probe region to 72.9% (Fig. 2D) . Our data indicate that fim2 is present in T44625 but contains low sequence identity to fim2 from RB50, and a substantial amount of sequence diversity exists within the fim2 genes of B. bronchiseptica.
Several well-characterized virulence factors are differentially expressed in T44625. Whole-genome transcriptome analysis was performed to determine genes differentially expressed between T44625 and RB50 (Fig. 3A) . A total of 113 genes were found to be expressed at significantly different levels by T44625 compared to RB50, with an overwhelmingly majority of them (92 genes) being downregulated ( Fig. 3A ; also see the supplemental material). The genes identified as downregulated in T44625 relative to RB50 include 23 chemotaxis-and motility-related genes, 13 transcriptional regulators, 6 of which are involved in regulating chemotaxis and motility genes, 10 metabolism-related genes, 4 periplasmic/exported or lipoprotein genes, and 12 transport-related genes (Fig. 3A and B) . The 21 genes found to be upregulated in T44625 relative to RB50 include 6 cell adhesion-related and/or colonization-related transcripts (fhaB, fhaC, fhaS, fimA, fimB, fimC, fimD, and bcfA), 3 metabolism-related transcripts, 3 periplasmic/exported or lipoprotein genes, 2 transport-related genes, and the transcription regulator bvgR (Fig. 3A and B) (38, (45) (46) (47) .
To provide an independent assessment of microarray expression measurements, expression of fhaB, bcfA, fimA, and flaA genes was analyzed by qRT-PCR. As expected, fhaB, bcfA, and fimA were upregulated in T44625 compared to RB50, while flaA was downregulated (Fig. 4) . Combined, these data demonstrate that several well-characterized virulence factors, most notably genes involved in adhesion, colonization, and motility, are differentially expressed in T44625 compared to RB50.
T44625 exhibits decreased motility. In B. bronchiseptica, the expression of flagellar synthesis genes is tightly regulated through a complex hierarchy requiring the presence of the frlAB regulatory locus (48, 49) . Relative to RB50, the expression of the flagellar structural gene flaA increases in RB54, the Bvg Ϫ phase-locked derivative of RB50, and decreases in RB53, a Bvg ϩ phase-locked derivative of RB50 (41, 42) . Compared to RB50, RB54 exhibits increased motility, whereas RB53 exhibits decreased motility. The downregulation of flagellar genes in T44625 compared to RB50 led us to hypothesize that T44625 would be less motile than RB50. To test this, a single colony of T44625, RB50, RB54, and RB53 were stab inoculated into soft-agar plates. As shown in Table 2 , the average migration for T44625 and RB50 was 2.61 Ϯ 0.42 and 6.93 Ϯ 0.61, respectively. Consistent with previous results, RB54 was highly motile, and RB53 exhibited the lowest motility. These results demonstrate that T44625 exhibits decreased motility compared to RB50. T44625 forms a thick ring at the air-liquid interface and displays increased aggregation and biofilm formation. We have demonstrated that flagellar production early during biofilm formation followed subsequently by repression is required for robust biofilm formation and maturation (36) . It has also been shown that FHA is required for efficient biofilm formation in both B. bronchiseptica and B. pertussis (50, 51) , and the presence of cyaA inhibits biofilm formation in B. bronchiseptica (51) . Given the repression of flagellar genes, lower motility, upregulation of fhaB, and absence of cyaA in T44625, we hypothesized that T44625 will exhibit increased biofilm formation compared to RB50. Previously, we demonstrated that B. bronchiseptica forms a ring or film of cells resembling bacterial biofilms at the air-liquid interface (39) . First, we compared the ability of T44625 and RB50 to form this ring. After 24 h of growth, while RB50 formed a thin film, T44625 formed an opaque thick ring at the air-liquid interface (Fig. 5A, closed arrow) . Additionally, compared to RB50, macroscopic aggregates of T44625 were observed to settle at the bottom of the test tube (Fig. 5A, open arrow) . Enhanced aggregate formation by T44625 compared to RB50 was also confirmed by microscopy (Fig. 5B) . To quantitate further the hyperaggregating properties of T44625, we determined the aggregation index (AI) of the two strains as described earlier (52) . The AI represents the fraction of cells present in aggregates. The AI of T44625 was significantly higher than that of RB50 at 2, 4, 6, and 8 h (Fig. 5C) . Additionally, when we quantified the percentage of cells remaining in suspension after disruption of aggregates, increased numbers of T44625 cells settled down at the bottom of the test tube at 6 and 20 h compared to RB50 (Fig. 5D ). In combination, these results suggest that T44625 displays an enhanced aggregation capacity. Since aggregation is often linked to increased biofilm formation, we analyzed the biofilm-forming capabilities of T44625. To quantify biofilm formation, cells attached to polystyrene plates were stained with crystal violet over a time course of 6, 24, 48, and 72 h. At 6 h, the biofilms formed by T44625 were similar to those of RB50 (Fig. 5E) . However, by 24 h, T44625 exhibited a slight increase in biofilm biomass compared to that of RB50 (Fig. 5E ). At later time points, 48 and 72 h, T44625 exhibited a significantly higher biofilm biomass than RB50 (Fig. 5E) . Taken together, these data demonstrate that compared to RB50, T44625 displays a hyperaggregation phenotype that correlates with hyperbiofilm formation.
T44625 exhibits enhanced adherence to respiratory epithelial cells. Given that the expression of several genes encoding known adhesins were upregulated in T44625, we hypothesized that T44625 would exhibit an increased in vitro adherence capacity compared to RB50. Since T44625 is a human isolate, we used cells of both animal and human origins, including rat lung epithelial cells (L2) and human alveolar epithelial cells (A549) (Fig. 6) . Compared to RB50, T44625 exhibited significantly enhanced attachment to both cell lines (Fig. 6) . Combined, these data link the increased expression of genes encoding known adhesins to increased cellular adherence of T44625.
T44625 persists in the mouse respiratory tract. Intranasal infection of mice with RB50 leads to the colonization of the nasal cavity, trachea, and lungs (6) . While mice eventually clear B. bronchiseptica from the lower respiratory tract, bacteria persist in the nasal cavity of infected mice for the lifetime of the animal (6) . We examined the relative ability of T44625 to colonize and persist in mice compared to RB50. Mice were intranasally inoculated with either RB50 or T44625, and the bacterial burdens of nasal septum, trachea, and lungs were determined at various time points postinoculation. Consistent with previous results, high CFU counts were recovered from all respiratory tract sites from RB50-inoculated mice at early time points (1 and 3 days postinoculation) followed by a relative reduction at 15 days (Fig. 7) . The CFU recovered from RB50-inoculated mice then began to decline in the trachea and the lungs and were cleared from these organs by 60 days postinoculation (Fig. 7) . In contrast, RB50 remained colonized in the nose at high numbers even at 60 days postinoculation, when approximately 3,000 CFU were recovered (Fig. 7) .
In contrast to RB50, significantly lower CFU were recovered from respiratory tract sites from T44625-inoculated mice at 1 and 3 days postinoculation (Fig. 7) . This decrease in bacterial numbers of T44625 was most pronounced at day 3 postinoculation, where 10 to 100 times fewer CFU were recovered from the nose, trachea, and lungs (Fig. 7) . However, at later time points, the colonization profile of T44625 was similar to that of RB50. These data demonstrate that although defective in establishing high bacterial burdens early during the infection process, the two strains did not differ in establishing persistent infections in mice.
T44625 expresses an antigenically distinct O-antigen serotype. B. bronchiseptica strains can produce one of two immunologically distinct O-antigen serotypes, either classical O-antigen loci (O1) or alternative O-antigen loci (O2) (40) . Given that T44625 contains the genes encoding the alternative O antigen, we hypothesized that it will express the O2 serotype. To test this, we compared the antigenic profiles of RB50 and T44625 using convalescent-phase sera from mice infected with either RB50 or T44625. Convalescent-phase sera collected from RB50-inoculated mice resulted in the recognition of several antigens in the WCE from RB50 (Fig. 8, left) . In contrast, a poor cross-reactivity of RB50-infected serum to WCE of T44625 was observed (Fig. 8,  left) . Antigens between 15 and 37 kDa have previously been shown to correspond to the O antigen of B. bronchiseptica (40, 53) . A broad smear of antigens between 15 and 37 kDa was observed in RB50, but there was a general lack of such cross-reactivity in T44625 (Fig. 8, left) .
In contrast to RB50-infected sera, sera collected from T44625-inoculated mice resulted in recognition of some antigens from T44625 WCE, but very few were from extracts prepared from RB50 (Fig. 8, right) . Additionally, T44625-infected sera recognized the broad smear of antigens from T44625 WCE but not from RB50 WCE (Fig. 8, right) . These data, along with those obtained by CGH analysis, suggest that RB50 and T44625 express two antigenically distinct O-antigen serotypes, and more specifically, T44625 expresses the O2 serotype.
DISCUSSION
The evolution of human pathogens and human infectious diseases is of considerable importance to physicians, researchers, and susceptible individuals. Many human pathogens are believed to frequently evolve from an animal reservoir when a pathogen strictly confined to animals gains the ability to infect humans. While there is relatively vigorous monitoring and scientific research on infectious diseases caused by strict human pathogens, there is an overall lack of such efforts for human diseases caused by pathogens of animal origin (54) . Continued and sustained research on human isolates of zoonotic pathogens will allow the understanding of the clinical significance, sequence divergence, phenotypic traits, and transmission pathways that lead to zoonotic infections. The bacterial pathogen B. bronchiseptica represents an experimentally tractable system to study these aspects of bacterial adaptations.
Of the nine Bordetella species identified to date, B. bronchiseptica is more genetically and clinically diverse than the other classical bordetella species (4, 8, 13, 14) . The human-adapted pathogens B. pertussis and B. parapertussis hu are believed to have evolved independently from a B. bronchiseptica ancestor (3, 7, 8) . Based on the currently used MLST-based scheme, B. bronchiseptica lineages are divided into two complexes (complexes I and IV), with complex IV being more closely related to B. pertussis and containing a higher proportion of human isolates and complex I strains mostly containing isolates from nonhuman mammalian hosts (8) . The major exception to this is ST27 strains, of which the overwhelming majority have been isolated from human hosts (8) . The goal of this study was to compare the virulence properties and pathogenic mechanisms of T44625, an ST27 strain, to the sequenced laboratory reference strain, RB50. Comparative genomic hybridization and transcriptome analyses were used to identify similarities and differences in genetic makeup and expression between T44625 and RB50.
We began by performing CGH analysis to identify coding regions present in T44625 that are either absent from RB50 or contain a high degree of sequence divergence compared to RB50. Focusing on virulence-related genes, five were identified as RDs in T44625. These included fimbrial serotype 2 (fim2), 3 O-antigenrelated genes (wbmS, wbmR, and wbmO), and bipA. PCR, Western blotting, and sequencing analysis further confirmed that T44625 expresses the alternative O antigen or O2 serotype and harbors a replacement of the cya operon with the ptp gene, and they demonstrated that the fim2 gene is present in T44625 but contains low sequence identity to fim2 from RB50 (17) .
When whole-genome transcriptome analysis was performed, we found that many BvgAS-regulated genes were differentially expressed between T44625 and RB50. Most notably, several adhesion-and colonization-related transcripts, including that of fhaB, bcfA, and fim, were upregulated, and many chemotaxis and motility-related transcripts were downregulated in T44625 relative to RB50. Increased expression of adhesion-related transcripts and decreased expression of motility-related transcripts correlated with increased in vitro cellular adherence and decreased motility on agar plates, respectively.
Among respiratory pathogens, including Bordetella species, the ability to form biofilms is critical for many aspects of their virulence (55) (56) (57) (58) (59) (60) . Biofilm formation appears to be especially important for the persistence of bacteria in CF infections (61) (62) (63) . Compared to RB50, T44625 displayed an enhanced ability for cellular aggregation and the formation of biofilms. To our knowledge, this is the first report documenting hyperbiofilm formation by a clinical isolate of B. bronchiseptica. Strains isolated from chronically infected cystic fibrosis patients often acquire mutations in regulatory and other genes resulting in hyperbiofilm formation (63) . It remains to be determined if similar mechanisms are operative in T44625.
Previously, we have shown that while B. bronchiseptica flagella are required for initial cell-surface interactions, repression of flagella at the postattachment stages resulted in maturation of biofilms (36) . We suggest that the observed downregulation of flagellar genes and lower motility of T44625 contribute to its hyperbiofilm capacity. Other potential mechanism for this phenotype are (i) the higher expression of FHA, Fim, and other adhesive factors in T44625 and (ii) the absence of the cyaA gene from T44625. We and others have previously shown that while FHA and Fim are required for Bordetella biofilm formation, the presence of cyaA is inhibitory (39, 50, 51) . Interestingly, we did not observe enhanced expression of the bpsABCD genes encoding the Bps polysaccharide, a Bordetella surface polysaccharide critical for biofilm development (10, 11) . Thus, it appears that unlike some other bacterial pathogens, overexpression of polysaccharide genes known to promote biofilm formation cannot be linked to the hyperbiofilm phenotype of T44625 (64) . Future gene expression analyses of biofilm cells of T44625 combined with transposon mutagenesis will allow detailed insights on the mechanisms that result in the hyperbiofilm phenotype. A recent analysis of complex IV strains of B. bronchiseptica isolated from humans revealed that these isolates displayed increased cytotoxicity compared to complex I strains. When examined in mice, a subset of complex IV strains was found to cause lethal infections, whereas another subset caused nonlethal infections similar to RB50 (65) . We examined the ability of T44625 to colonize and cause persistent infections in mice. Although defective in establishing high bacterial burdens early during the infection process, T44625 established a persistent infection in the mouse nasal cavity similar to that of RB50. The decreased colonization levels of T44625 observed at early time points is in direct contrast to its enhanced in vitro cellular adherence. We propose that the hyperbiofilm phenotype of T44625 results in subsequently enhanced colonization at later time points, resulting in levels of persistence in the mouse nose similar to those of RB50. Future mutational analyses will delineate the contribution of specific virulence-related genes in respiratory infection of T44625.
In conclusion, we have shown that a human isolate of a largely considered animal pathogen contains a distinct genomic repertoire of virulence-associated genes and differentially expresses these genes compared to the reference laboratory strain. The differential expression pattern of virulence-related genes correlated with the exhibition of unique pathogenic phenotypes. We propose that these differential mechanisms contribute to the zoonotic potential of T44625. These results provide a foundation for future studies geared toward understanding the successful zoonotic potential of not only T44625 and other human isolates of B. bronchiseptica but also other bacterial species.
